Practical significance of biomarkers in axial spondyloarthritis: updates on diagnosis, disease activity, and prognosis

AD Diaconu, A Ceasovschih, V Șorodoc… - International journal of …, 2022 - mdpi.com
Axial spondyloarthritis (axSpA) is a chronic inflammatory disease that can lead to ankylosis
by secondary ossification of inflammatory lesions, with progressive disability and a …

B cell involvement in the pathogenesis of ankylosing spondylitis

R Wilbrink, A Spoorenberg, GMPJ Verstappen… - International journal of …, 2021 - mdpi.com
Extensive research into ankylosing spondylitis (AS) has suggested the major role of
genetics, immune reactions, and the joint–gut axis in its etiology, although an ultimate …

[HTML][HTML] Updates on ankylosing spondylitis: pathogenesis and therapeutic agents

SH Kim, SH Lee - Journal of rheumatic diseases, 2023 - synapse.koreamed.org
Ankylosing spondylitis (AS) is an autoinflammatory disease that manifests with the unique
feature of enthesitis. Gut microbiota, HLA-B* 27, and biomechanical stress mutually …

Human Leukocyte Antigen B27‐Negative Axial Spondyloarthritis: What Do We Know?

A Deodhar, T Gill, M Magrey - ACR Open Rheumatology, 2023 - Wiley Online Library
Axial spondyloarthritis (axSpA) is a chronic, immune‐mediated disease characterized by
inflammatory axial skeleton involvement and extra‐musculoskeletal manifestations. The …

[HTML][HTML] Comparative analysis between ankylosing spondylitis and axial psoriatic arthritis patients

MM Abdelaziz, N Ismail, AM Gamal, R Lafy… - The Egyptian …, 2022 - Elsevier
Aim of the work To compare clinical aspects, disease activity, spinal mobility, and
radiographic findings between ankylosing spondylitis (AS) and axial psoriatic arthritis …

[PDF][PDF] S, orodoc

AD Diaconu, I Ostafie, A Ceasovschih - Int. J. Mol. Sci, 2022 - pdfs.semanticscholar.org
Axial spondyloarthritis (axSpA) is a chronic inflammatory disease that can lead to ankylosis
by secondary ossification of inflammatory lesions, with progressive disability and a …

Anti-CD74 antibodies in spondyloarthritis: a systematic review and meta-analysis

S Xu, X Zhang, Y Chen, Y Ma, J Deng, X Gao… - Seminars in Arthritis and …, 2021 - Elsevier
Objective There is still an unmet need for a simple and reliable biomarker for the diagnosis
of spondyloarthritis. Recent studies indicated that anti-CD74 antibody could act as a …

Macrophage migration inhibitory factor (MIF) and IgA anti CD74 antibodies in Indian patients with enthesitis-related arthritis category of Juvenile idiopathic arthritis

A Balakrishnan, S Majumder, S Guleria… - Rheumatology …, 2023 - Springer
Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine and has been
implicated in pathogenesis of ankylosing spondylitis (AS). CD 74 is the receptor for MIF and …

Exploring T Cell and NK Cell Involvement in Ankylosing Spondylitis Through Single‐Cell Sequencing

T Chen, S Ning, J Zhu, X Zhan, C Zhou… - Journal of Cellular …, 2024 - Wiley Online Library
To uncover the complex immune mechanisms driving inflammation in ankylosing spondylitis
and lay the groundwork for identifying new therapeutic targets and innovative approaches …

Circ_0049979 ameliorates myocardial infarction through improving Cx43-mediated endothelial functions

M Sun, S Zhai, Y Gao, N Hu, R Wang… - Toxicology and Applied …, 2024 - Elsevier
Endothelial injury is a fundamental pathogenesis of coronary atherosclerotic heart disease
(CHD). Circular RNAs (circRNAs) are important post-transcriptional regulators in many …